|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.23 EUR | -0.33% |
|
+0.55% | -7.85% |
| 07-10 | Sanofi Receives Fda Approval for Subcutaneous Sarclisa Escena Administered Via On-Body Injector | CI |
| 07-10 | Sanofi Wins US FDA Approval for Subcutaneous Sarclisa Escena in Multiple Myeloma | MT |
98c99dd34296a60f.j0RsAsk5yAsLh9-vmk37X91bBnN3_h0QEJV-wiGY--4.wx00Q_0UhXhC7uv643_CEr46bhwFlEljI9xTpk_LqK3QBx9R-m-4aH_pjg~90b7da5545b3228af6f4f30e9ad6c60f
- Stock Market
- Stocks
- SAN Stock
- Charts Sanofi
- News Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















